|
🐬
|
cPLA2 is phosphorylated and activated by MAP kinase
Lih-Ling Lin,
M. Wartmann,
A. Y. Lin,
J. Knopf,
A. Seth,
R. Davis
|
10 |
1993 |
10
🐬
|
|
🐜
|
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.
17 auth.
V. Guagnano,
P. Furet,
C. Spanka,
V. Bordas,
Mickaël Le Douget,
C. Stamm,
J. Brueggen,
M. Jensen,
C. Schnell,
Herbert A. Schmid,
...
M. Wartmann,
J. Berghausen,
P. Drueckes,
A. Zimmerlin,
D. Bussiere,
J. Murray,
Diana Graus Porta
|
8 |
2011 |
8
🐜
|
|
🐜
|
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors.
20 auth.
S. Vora,
D. Juric,
Nayoon Kim,
M. Mino‐Kenudson,
Tiffany Huynh,
C. Costa,
Elizabeth Lockerman,
Sarah F. Pollack,
Manway Liu,
Xiaoyan Li,
...
J. Lehár,
M. Wiesmann,
M. Wartmann,
Yan Chen,
Z. Cao,
Maria C. Pinzon-Ortiz,
Sunkyu Kim,
R. Schlegel,
A. Huang,
J. Engelman
|
8 |
2014 |
8
🐜
|
|
🐬
|
Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1
Y. Ward,
Shashi Gupta,
P. Jensen,
M. Wartmann,
R. Davis,
K. Kelly
|
8 |
1994 |
8
🐬
|
|
🐜
|
AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
15 auth.
P. Traxler,
P. Allegrini,
R. Brandt,
J. Brueggen,
R. Cozens,
D. Fabbro,
K. Grosios,
H. Lane,
P. Mcsheehy,
J. Mestan,
...
T. Meyer,
Careen K. Tang,
M. Wartmann,
J. Wood,
G. Caravatti
|
8 |
2004 |
8
🐜
|
|
🐜
|
Extended kinase profile and properties of the protein kinase inhibitor nilotinib.
10 auth.
P. Manley,
P. Drueckes,
G. Fendrich,
P. Furet,
J. Liebetanz,
G. Martiny-Baron,
...
J. Mestan,
J. Trappe,
M. Wartmann,
D. Fabbro
|
7 |
2010 |
7
🐜
|
|
🐬
|
Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity.
K. Altmann,
M. Wartmann,
T. O'reilly
|
7 |
2000 |
7
🐬
|
|
🦁
|
The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
M. Wartmann,
D. Campbell,
A. Subramanian,
S. Burstein,
R. Davis
|
7 |
1995 |
7
🦁
|
|
🦁
|
The biology and medicinal chemistry of epothilones.
M. Wartmann,
K. Altmann
|
7 |
2012 |
7
🦁
|
|
🐬
|
Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669.
I. Northwood,
Fernando Gonzalez,
M. Wartmann,
D. Raden,
Roger J. Davis
|
7 |
1991 |
7
🐬
|
|
🐜
|
STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake.
9 auth.
K. Pietras,
M. Stumm,
M. Hubert,
E. Buchdunger,
K. Rubin,
C. Heldin,
...
P. Mcsheehy,
M. Wartmann,
A. Ostman
|
7 |
2003 |
7
🐜
|
|
🐜
|
Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib.
9 auth.
P. Manley,
N. Stiefl,
S. Cowan-Jacob,
Susan Kaufman,
J. Mestan,
M. Wartmann,
...
M. Wiesmann,
R. Woodman,
N. Gallagher
|
7 |
2010 |
7
🐜
|
